Welcome to Advanced Search

Azin2-Flox

Strain Name：C57BL/6Smoc-Azin2^{em1(flox)Smoc}
Strain State：Developing | Cat. NO.：NM-CKO-260411

These mice carry loxP sites flanking exon 5-6 of Azin2 gene. When crossed with a Cre recombinase-expressing strain, this strain is useful in eliminating tissue-specific conditional expression of Azin2 gene.

Azin2-KO

Strain Name：C57BL/6Smoc-Azin2^em1Smoc
Strain State：Developing | Cat. NO.：TBD

Exon 4-5 of Azin2 gene was deleted to generate Azin2 knockout mice.

Gadl1-Flox

Strain Name：C57BL/6Smoc-Gadl1^{em1(flox)Smoc}
Strain State：Developing | Cat. NO.：TBD

These mice carry loxP sites flanking target exons of Gadl1 gene. When crossed with a Cre recombinase-expressing strain, this strain is useful in eliminating tissue-specific conditional expression of Gadl1 gene.

Gadl1-KO

Strain Name：C57BL/6Smoc-Gadl1^em1Smoc
Strain State：Developing | Cat. NO.：TBD

Exon 3 of Gadl1 gene was deleted to generate Gadl1 knockout mice.

Webinar on Advances in Antibody-Drug Conjugates (ADCs) Development & Preclinical Models

Antibody-Drug Conjugates ADC Development Preclinical Models Targeted Cancer Therapies GenoBioTX ADC Webinar Biopharma Research Oncology Biochemistry Cancer Treatment Preclinical Evaluation Monoclonal Antibodies Small Molecule Drugs

Join us for a webinar on June 26th, 2024, exploring the development and preclinical evaluation of Antibody-Drug Conjugates (ADCs). Learn from Dr. Hua Wei, VP of the Industrial Clients Department at GenoBioTX, about ADC components, mechanisms, historical evolution, and future directions.

ADC Antibody Development

Super-trillion Innovative Antibody Drug Discovery Platform

Integrated Service for Antibody Discovery from Target to PCC

Solutions from PCC to IND Drug Development

Innovative Antibody Discovery With Super-trillion Ab Libraries